Patents by Inventor Rengasayee Veeraraghavan

Rengasayee Veeraraghavan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230218716
    Abstract: Disclosed herein is a method for treating atrial fibrillation (AF) or reentrant ventricular arrhythmias in a subject that involves administering to the subject a therapeutically effective amount of a gap junction or pannexin channel inhibitor in an amount effective to preserve barrier function. In some embodiments, the subject has paroxysmal AF.
    Type: Application
    Filed: May 6, 2021
    Publication date: July 13, 2023
    Inventors: Rengasayee VEERARAGHAVAN, Louisa MEZACHE
  • Patent number: 8808668
    Abstract: The present invention provides methods and compositions for modulating x-ray attenuation, where the x-ray attenuation compound can comprise a molecule having at least two conformational states, a first k-edge atom attached to the molecule at a first position, and a second k-edge atom attached to the molecule at a second position, where the molecule changes from a first conformational state to a second conformational state in response to an external stimulus. Additionally, a first interatom distance between the first k-edge atom and the second k-edge atom in the first conformational state can be within a first harmonic error of 0 to about 0.2, and a second interatom distance between the first k-edge atom and the second k-edge atom in the second conformational state can be within a second harmonic error of about 0.8 to 1.0.
    Type: Grant
    Filed: April 14, 2009
    Date of Patent: August 19, 2014
    Assignee: University of Utah Research Foundation
    Inventors: Steven Poelzing, Rengasayee Veeraraghavan, Adam Smoot
  • Publication number: 20090266995
    Abstract: The present invention provides methods and compositions for modulating x-ray attenuation, where the x-ray attenuation compound can comprise a molecule having at least two conformational states, a first k-edge atom attached to the molecule at a first position, and a second k-edge atom attached to the molecule at a second position, where the molecule changes from a first conformational state to a second conformational state in response to an external stimulus. Additionally, a first interatom distance between the first k-edge atom and the second k-edge atom in the first conformational state can be within a first harmonic error of 0 to about 0.2, and a second interatom distance between the first k-edge atom and the second k-edge atom in the second conformational state can be within a second harmonic error of about 0.8 to 1.0.
    Type: Application
    Filed: April 14, 2009
    Publication date: October 29, 2009
    Inventors: Steven Poelzing, Rengasayee Veeraraghavan, Adam Smoot